X4 Pharmaceuticals Inc. (XFOR)

0.22

-0.02 (-6.94%)

At close: Apr 01, 2025, 3:59 PM

0.22

-0.50%

After-hours: Apr 01, 2025, 07:55 PM EDT

X4 Pharmaceuticals Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-37.45M	-101.17M	-93.87M	-88.7M	-62.13M
Depreciation & Amortization	796K	419K	513K	499K	351K
Stock-Based Compensation	8.2M	8.69M	5.2M	6.18M	5.43M
Other Working Capital	n/a	-890K	2.31M	-2.66M	-5.09M
Other Non-Cash Items	-102.45M	-4.79M	5.32M	19.29M	7.38M
Deferred Income Tax	n/a	n/a	n/a	-6.68M	-5.78M
Change in Working Capital	n/a	344K	5.74M	-1.5M	-4.06M
Operating Cash Flow	-130.9M	-96.51M	-77.1M	-70.91M	-58.82M
Capital Expenditures	-326K	-60K	-103K	-615K	-1.36M
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-57.13M	-16.82M	-4.8M	n/a	n/a
Sales Maturities Of Investments	26.45M	2M	n/a	n/a	n/a
Other Investing Acitivies	98M	n/a	4.8M	n/a	n/a
Investing Cash Flow	66.99M	-14.88M	-103K	-615K	-1.36M
Debt Repayment	20M	20.44M	-795K	n/a	12.39M
Common Stock Repurchased	n/a	n/a	n/a	-2M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	294K	8.08M	-4.61M	260K	284K
Financial Cash Flow	20.29M	88.52M	117.23M	74.25M	12.39M
Net Cash Flow	-43.77M	-22.78M	39.92M	2.41M	-47.38M
Free Cash Flow	-131.23M	-96.57M	-77.2M	-71.52M	-60.18M